A Phase 3 Multi-Center Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase in Adolescent Subjects (Ages 12-17) with Phenylketonuria Featuring an Open-Label Randomized Two-Arm (Active vs Diet-Only Control) Design
Phenylketonuria (PKU) is a rare lifelong condition where the body cannot break down phenylalanine (Phe), a substance found in protein. If Phe builds up in the blood, it can cause problems with learning and brain health. Most young people with PKU have to stick to a very strict low-protein diet. This trial is studying a medicine called pegvaliase (Palynziq) in adolescents aged 12 to 17. The medicine is an enzyme given as an injection under the skin that helps break down Phe in the body. Teenagers taking part are randomly put into one of two groups: one group receives pegvaliase injections, while the other continues their standard low-protein diet alone. Researchers want to check the safety of the medicine, look for any side effects, and see if it allows teenagers to safely eat more natural protein from everyday foods.
Em resumo
Sobre o que é este estudo?
Phenylketonuria, or PKU, is a rare genetic condition. People born with PKU cannot properly process phenylalanine, often called 'Phe'. Phe is a natural building block of protein found in foods like meat, dairy, eggs, nuts, and even bread. Without treatment, Phe levels rise dangerously high in the blood and can harm the brain. For decades, the main way to manage PKU has been a very strict, low-protein diet combined with special medical drinks. Sticking to this diet can be very challenging, especially for teenagers.
This study looks at a treatment called pegvaliase (brand name Palynziq). Pegvaliase acts like a replacement enzyme in the body, breaking down Phe before it reaches harmful levels. The medicine is already used by some adults with PKU, but researchers need to confirm how safe and effective it is for adolescents aged 12 to 17.
In this trial, teenagers are placed into one of two groups. One group will take the study medicine as regular injections under the skin, while the other group will stay on their usual diet-only care for comparison. The main goal is to check for side effects and ensure the medicine is safe. Doctors also want to see whether teenagers taking pegvaliase can safely add more regular protein into their daily meals without raising their blood Phe levels.
Pontos principais
- Tests pegvaliase (Palynziq) injections for teenagers aged 12 to 17 with PKU.
- Compares the new medicine against standard low-protein diet management.
- Aims to check the safety of the medicine and see if it allows more normal protein in the diet.
- Requires regular clinic visits for blood tests, heart checks, and physical exams.
- Participation is completely voluntary and you can leave the study at any time.
Quem pode ser elegível?
This trial is designed specifically for teenagers aged 12 to 17 who have been diagnosed with phenylketonuria (PKU). Both boys and girls can take part.
To be eligible, young people generally need to have blood Phe levels that remain higher than recommended despite their current diet or treatment. Participants and their families must also be willing to attend regular clinic appointments and follow the study instructions carefully.
A teenager might not be able to join if they have had severe allergic reactions to similar treatments in the past, have other serious medical conditions, or are currently taking part in another clinical trial. The study team will review medical records and run initial health checks to decide if joining is safe and suitable.
Este estudo pode ser adequado para você?
Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.
- Aged between 12 and 17 years old.
- Have a confirmed diagnosis of phenylketonuria (PKU).
- Have blood Phe levels that are currently high or difficult to manage.
- Able to attend regular hospital check-ups and monitoring visits.
- Willing and able to take injections under the skin if chosen for the medicine group.
O que envolve a participação?
Taking part involves regular visits to a specialist hospital clinic. Teenagers are randomly placed into either the medicine group or the diet-only group. If chosen for the medicine group, the treatment is given as an injection under the skin using a pre-filled syringe. Full training is provided so that injections can be given safely at home. Throughout the trial, the healthcare team will monitor participants closely. Visits will include physical examinations, blood and urine tests, heart checks (ECGs), and checks of temperature and blood pressure. The team will also carefully track what participants eat to see if their protein intake can be adjusted. The study lasts for several months to ensure young people are supported and their health is closely tracked.
Riscos e benefícios potenciais
Localizações (1)
- —Não verificadoAlemanha
Perguntas frequentes
What is phenylketonuria (PKU)?
PKU is a genetic condition where the body cannot break down phenylalanine (Phe), a part of protein. Without treatment, Phe builds up in the blood and can cause damage to the brain.
How does pegvaliase work?
Pegvaliase is an enzyme that works by breaking down Phe in the blood, helping to keep Phe levels in a safer, lower range.
How is the study medicine taken?
It is given as an injection just under the skin using a small pre-filled syringe. The study team teaches families how to do this safely at home.
Can we choose which group our child joins?
No. A computer system places participants into either the medicine group or the diet-only group at random. This makes the scientific results fair and reliable.
Can my child immediately start eating normal food?
No. Any dietary changes must be made very slowly and under the strict supervision of the study doctors and dietitians, based on regular blood test results.
Como saber mais
Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.
Interessado em participar?
Discussão
Discussão da comunidade
Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.